288 related articles for article (PubMed ID: 2305221)
1. [Evaluation of tolerance, efficacy and safety of 3-year simvastatin use in the treatment of primary hypercholesterolemia].
Darioli R; Bovet P; Brunner HR; Bercher L
Schweiz Med Wochenschr; 1990 Jan; 120(4):85-91. PubMed ID: 2305221
[TBL] [Abstract][Full Text] [Related]
2. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
Brocard JJ; Keller U; Oberhänsli A; Riesen WF
Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314
[TBL] [Abstract][Full Text] [Related]
3. [Effects of simvastatin on atherogenic blood lipid pattern].
Alessandri C; Peverini F; Basili S; Barsi R; Paradiso M; Marotta P; Censi C; Cordova C; Balsano F
Recenti Prog Med; 1991 Apr; 82(4):225-9. PubMed ID: 1857842
[TBL] [Abstract][Full Text] [Related]
4. [Simvastatin in the treatment of hypercholesterolemia].
Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
[TBL] [Abstract][Full Text] [Related]
5. [HMG-CoA reductase inhibitors in familial hypercholesterolemia. Therapy with simvastatin alone and in combination with cholestyramine in low dosage; a report of 2 years experiences].
Geisel J; Oette K; Burrichter H
Fortschr Med; 1990 Feb; 108(4):71-2, 75-6. PubMed ID: 2312032
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
Leclercq V; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
[TBL] [Abstract][Full Text] [Related]
8. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
[TBL] [Abstract][Full Text] [Related]
9. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
[TBL] [Abstract][Full Text] [Related]
10. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
Pappu AS; Bacon SP; Illingworth DR
J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
Mol MJ; Stuyt PM; Stalenhoef AF
Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
French JK; White HD; Greaves SC
N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
[TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
Pernigotti L; Bo M; Poli L; Zanocchi M; Fiandra U; Pedrazzini V; Fabris F
Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557
[TBL] [Abstract][Full Text] [Related]
16. [Effects of simvastatin on plasma levels of lipids, lipoproteins and apolipoproteins in primary hypercholesterolemia].
Caruzzo C; Uslenghi E; Varbella F; Caruzzo E; Marcolongo M; Brusca A
Minerva Cardioangiol; 1989 Dec; 37(12):509-15. PubMed ID: 2695857
[TBL] [Abstract][Full Text] [Related]
17. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
Prat H; Román O; Pino E
Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
[TBL] [Abstract][Full Text] [Related]
18. [Simvastatin in the treatment of familial hypercholesterolemia].
Ceska R; Sobra J; Procházková R; Kvasilová M
Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650
[TBL] [Abstract][Full Text] [Related]
19. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis].
Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J
Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of micronized fenofibrate and simvastatin in patients with primary type IIa or IIb hyperlipidemia.
Farnier M; Bonnefous F; Debbas N; Irvine A
Arch Intern Med; 1994 Feb; 154(4):441-9. PubMed ID: 8117177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
